Business Plan on New Age BIOTECH

New Age BIOTECH, Inc. was formed develop, market, and license its patented zinc peptide technology. The company has seen total revenue grow from $2.7 million to an estimated $11.1 million in 200B. Although New Age BIOTECH experienced a net loss of $4.5 million profit of $500,000 is projected in 2008.Through various supply and distribution agreements for the mass retail market, NewAge BIOTECH, Inc., has accelerated its entry into the consumer market.